InfeXn is one of the first standalone reference laboratories in India offering a comprehensive TB test menu at a single one-stop location.
Microbiology is practiced with a macro focus on diagnosis and treatment interpretative support of infectious diseases. KNOW MORE
We conduct PCRs for over 200 pathogens, which is the widest range of tests available with any laboratory in India. KNOW MORE
At InfeXn, our widest range of multipleX PCRs with an India-specific pathogen panel offers more than 200 assays for esoteric pathogens. KNOW MORE
The Infectious Disease Serology section at InfeXn offers a diverse range of tests in the areas of viral, bacterial, and parasitological serology. KNOW MORE
InfeXn offers a wide range of customized solutions for the environmental microbiological monitoring of hospitals, labs, and clinics.
Tests designed for rapid identification of the causative agents of infectious diseases
Tests performed annually for rapid detection and identification of microbial pathogens
Educational sessions focused on advanced diagnostic techniques for emerging microbiology and infectious diseases
We offer multiple ranges of real-time PCR machines to carry out different tests and deliver time-bound results; the right infrastructure and expertise enable top-quality interpretations for tests.
Our DNA hybridization-based assays are well known for their ability to detect and quantify specific bacteria.
With our multipleX PCR, we bring forth a paradigm shift - from a disease approach to the syndromic approach towards the bloodstream, gastrointestinal, respiratory, and central nervous system infections.
We provide a range of mutation studies for checking genetic disorders. We can analyse any gene to confirm a mutation that has been suspected.
We are a core facility providing gene sequencing service for the best, most cutting-edge combination of sequencing approaches for varying needs of our customers.
We develop customised immunological assays or transfer existing assay technology with assay validation, data analysis, and validation of test results.
With susceptibility studies, we detect possible drug resistance in common pathogens and assure susceptibility to drugs of choice for particular infections.
Syndromic multipleX panel technology has brought about a paradigm shift, from a disease approach to the syndromic approach.